Canada Life’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
Other funds holding SNDX
Canada Life's SNDX Position: Q3 2026 in Review
Canada Life held its Syndax Pharmaceuticals (SNDX) position steady in Q3 2026 at 7,182 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #1624.
Canada Life first reported a position in SNDX in Q4 2020 and has held it in 24 quarters since. The position peaked at $424K in Q2 2024. 169 funds tracked by Wall St. Rank hold SNDX as of Q3 2026.
- Canada Life held 7,182 shares of Syndax Pharmaceuticals worth $135K as of Q3 2026.
- Canada Life left its Syndax Pharmaceuticals share count unchanged in Q3 2026.
- Syndax Pharmaceuticals made up ﹤0.01% of Canada Life's portfolio in Q3 2026, its #1624 holding.
- Canada Life first reported a position in Syndax Pharmaceuticals in Q4 2020 and has held it in 24 quarters since.
- Canada Life's Syndax Pharmaceuticals position peaked at $424K in Q2 2024.
- 169 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q3 2026.
Based on Canada Life's 13F filing for Q3 2026, filed 13 Nov 2026.